Skip to content

Is laser acupuncture an effective treatment for shoulder and neck pain in office workers?

The feasibility and therapeutic efficacy of a two-week low-level laser acupuncture therapy for shoulder and neck pain in office workers: a single-blind, double-armed, randomised controlled trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12621000426886
Enrollment
110
Registered
2021-04-16
Start date
2021-11-30
Completion date
2022-06-01
Last updated
2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Shoulder and neck pain (SNP) are common and burdensome conditions in office workers with a high prevalence. It is a serious public health problem and has a significant detrimental impact on one’s quality of life, physical functioning, economic structure, families, employers and health care system. Lengthened working hours on the computer, prolonged sitting position, and static postures are the most contributing factors, and medication and physiotherapy were the most common intervention strategies that people chose to manage their pain. The low-level laser therapy (LLLT), also known as cold laser, photobiomodulation, applies specific wavelengths and low power density, has been shown to be an additional option in the SNP management to relive pain and re-establish quality of life. LLLT can promotes analgesic and anti-inflammatory effects, improve blood circulation, boosts immunity and speeds up wound healing, with no reported adverse effects and well received by many patients. Low-level laser acupuncture (LLLA), is one of the recent technological developments (e.g., electroacupuncture) in the practice of acupuncture, which integrate the cutting-edge laser technology and thousands of years old TCM modality. Instead of the needle stimulation on the acupuncture points, low intensity non thermal laser irradiation is applied to elicit the cellular level’s physiologic effects with sufficient energy. It is, therefore, non-invasive, painless, non-infectious and safe to use. LLLA has become increasingly attractive for patients with needle phobias, older people and children. Several studies demonstrated that LLLA is a promising modality in pain management. However, there is no consolidated evidence for LLLA in managing shoulders and neck pain, and more studies in this field are required to provide updated evidence. Therefore, this study aims to provide compelling evidence of the feasibility and therapeutic efficacy of LLLA for office workers with SNP. We anticipate, based on past research, the LLLA we will provide may be helpful in reducing levels of SNP. We hope that the results of our research can be used to inform our knowledge about how to better manage SNP that many office workers are suffering.

Interventions

Intervention group: In addition to usual care, participants will receive LLLA from a licensed acupuncturist at ECU Acupuncture Research Clinic. 10-20 minutes per session, three times a week for two weeks. The parameters of 3B Laser Pen (200mW) used for the intervention are wavelength of 808 nm in continuous wave mode, each pressure point receives 20 seconds of energy (4J) with 5 minutes being the maximum treatment time (60 J). At the end of two weeks receiving the therapy, participants will rece

Intervention group: In addition to usual care, participants will receive LLLA from a licensed acupuncturist at ECU Acupuncture Research Clinic. 10-20 minutes per session, three times a week for two weeks. The parameters of 3B Laser Pen (200mW) used for the intervention are wavelength of 808 nm in continuous wave mode, each pressure point receives 20 seconds of energy (4J) with 5 minutes being the maximum treatment time (60 J). At the end of two weeks receiving the therapy, participants will receive an online link to complete the post-intervention questionnaires.

Sponsors

Edith Cowan University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1) aged between 18-65 years 2) working more than 28 h a week with sedentary office work 3) moderate to severe SNP (VAS > 5/10 & SF-MPQ > 2/45) for more than three months

Exclusion criteria

Women who are pregnant, people with cancer, high sensitivity to light, or other symptoms of unknown cause will not be eligible.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 13, 2026